Amylyx Pharmaceuticals News and Activities

Amylyx Pharmaceuticals is one of the...

• Russell 3000;
• TOB Iconic 10,000.

Amylyx Pharmaceuticals is a company listed under the stock ticker AMLX (US).

Amylyx Pharmaceuticals has a direct presence in 2 countries.

View the org chart displaying its 24 main executives

Most searched biographies at Amylyx Pharmaceuticals

• Josh Cohen, Co-Chief Executive Officer and Director
• George Milne, Chairman of the Board
• Daphne Quimi, Director

Popular executive movements at Amylyx Pharmaceuticals

• Baoguang Han has joined the company as Vice President, Biostatistics  (posted on February 19 2026).

Create your alert
to follow the executive moves at Amylyx Pharmaceuticals.

Amylyx Pharmaceuticals has 1,913 competitors including Sanofi (France), Eli Lilly (United States (USA)) and Moderna (United States (USA)).

Popular M&A news in Pharmaceuticals

• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Contraline has just announced a $93 Million fundraising (posted on June 3 2026).
• Hims & Hers has acquired Eucalyptus (posted on June 2 2026).

Popular contacts in Pharmaceuticals

• Joaquin Duato - Chief Executive Officer and Chairman of the Board at Johnson & Johnson
• Richard Saynor - Chief Executive Officer at Sandoz
• Robert Ford - Chief Executive Officer and Chairman of the Board at Abbott

Learn more about the Pharmaceuticals industry

Press releases by Amylyx Pharmaceuticals

• Amylyx Pharmaceuticals Announces Formal Intention to Remove RELYVRIO®/ALBRIOZA™ from the Market; Provides Updates on Access to Therapy, Pipeline, Corporate Restructuring, and Strategy
• HomepageBack ButtonSearch IconFilter Icon
• News

Social media about Amylyx Pharmaceuticals

• Amylyx Pharmaceuticals on Wikipedia, Google News & Yahoo Finance
• Amylyx Pharmaceuticals on LinkedIn, X (Twitter) & YouTube